Last 12 months
Inside the activity.
6 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 3 | 0 |
| Dec 2025 | 3 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 03, 2026 Filed Jul 20, 2026 21:28 UTC |
Rudick Brian BenjaminChief Strategy Officer
|
GrantCommon Stock | 400,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-26-004401 · form4.xml · nonDerivative · entry 1 Rudick Brian Benjamin · CIK 0002068669 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,238,597 F1 · shares: Represents restricted stock granted pursuant to the Issuer's 2019 Incentive Stock Plan, as amended, that vests in four equal installments on October 1, 2026, January 1, 2027, April 1, 2027 and July 1, 2027, subject to continued service. Read SEC document |
| July 03, 2026 Filed Jul 20, 2026 21:28 UTC |
Dugan LawrenceDirector
|
GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-26-004402 · form4.xml · nonDerivative · entry 1 Dugan Lawrence · CIK 0001864559 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 216,389 F1 · shares: Represents restricted stock granted pursuant to the Issuer's 2019 Incentive Stock Plan, as amended, that vests in four equal quarterly installments, with full vesting on July 1, 2027, subject to continued service. Read SEC document |
| July 03, 2026 Filed Jul 20, 2026 21:27 UTC |
MARSHALL ALLANDirector · Chief Executive Officer
|
GrantCommon Stock | 2,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-26-004400 · form4.xml · nonDerivative · entry 1 MARSHALL ALLAN · CIK 0001279925 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,046,261 F1 · shares: Represents restricted stock granted pursuant to the Issuer's 2019 Incentive Stock Plan, as amended, that vests in four equal installments on October 1, 2026, January 1, 2027, April 1, 2027 and July 1, 2027, subject to continued service Read SEC document |
| July 03, 2026 Filed Jul 20, 2026 21:27 UTC |
Norstrud Andrew JamesDirector · Chief Financial Officer
|
GrantCommon Stock | 400,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-26-004399 · form4.xml · nonDerivative · entry 1 Norstrud Andrew James · CIK 0001311402 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,049,138 F1 · shares: Represents restricted stock granted pursuant to the Issuer's 2019 Incentive Stock Plan, as amended, that vests in four equal installments on October 1, 2026, January 1, 2027, April 1, 2027 and July 1, 2027, subject to continued service. Read SEC document |
| July 03, 2026 Filed Jul 20, 2026 21:36 UTC |
Salkind GeneDirector
|
GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-26-004404 · form4.xml · nonDerivative · entry 1 Salkind Gene · CIK 0001592481 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 318,750 F1 · shares: Represents restricted stock granted pursuant to the Issuer's 2019 Incentive Stock Plan, as amended, that vests in four equal quarterly installments, with full vesting on July 1, 2027, subject to continued service. Read SEC document |
| December 23, 2025 Filed Dec 24, 2025 00:53 UTC |
MARSHALL ALLANDirector · Chief Executive Officer
|
PurchaseCommon Stock | 50,000 | $1.80 | $90,000.00 |
DisclosureSEC source: 0001477932-25-009188 · form4.xml · nonDerivative · entry 1 MARSHALL ALLAN · CIK 0001279925 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,046,261 Read SEC document |
| December 16, 2025 Filed Dec 17, 2025 23:43 UTC |
MARSHALL ALLANDirector · Chief Executive Officer
|
PurchaseCommon Stock | 50,000 | $2.07 | $103,500.00 |
DisclosureSEC source: 0001477932-25-009027 · form4.xml · nonDerivative · entry 3 MARSHALL ALLAN · CIK 0001279925 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,996,261 Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 23:43 UTC |
MARSHALL ALLANDirector · Chief Executive Officer
|
PurchaseCommon Stock | 100,000 | $2.07 | $207,000.00 |
DisclosureSEC source: 0001477932-25-009027 · form4.xml · nonDerivative · entry 2 MARSHALL ALLAN · CIK 0001279925 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,946,261 Read SEC document |
| November 20, 2025 Filed Nov 21, 2025 11:32 UTC |
Salkind GeneDirector
|
PurchaseCommon Stock | 50,000 | $2.55 | $127,500.00 |
DisclosureSEC source: 0001477932-25-008535 · form4.xml · nonDerivative · entry 1 Salkind Gene · CIK 0001592481 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Trustee Disclosed balance after: 218,750 F1 · ownership.direct: 50,000 shares were purchased at $2.55 per share on the open market through the Marital Trust GST subject U/W/O Leopold Salkind Gene Salkind, Trustee. These shares are considered indirect ownership of Gene Salkind. Read SEC document |
| November 17, 2025 Filed Nov 19, 2025 02:40 UTC |
Salkind GeneDirector
|
PurchaseCommon Stock | 100,000 | $2.81 | $281,000.00 |
DisclosureSEC source: 0001477932-25-008466 · form4.xml · nonDerivative · entry 2 Salkind Gene · CIK 0001592481 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Trustee Disclosed balance after: 168,750 F1 · ownership.direct: 100,000 shares were purchased at $2.81 per share on the open market through the Marital Trust GST subject U/W/O Leopold Salkind Gene Salkind, Trustee. These shares are considered indirect ownership of Gene Salkind. Read SEC document |
| November 17, 2025 Filed Nov 19, 2025 02:40 UTC |
Salkind GeneDirector
|
PurchaseCommon Stock | 100,000 | $2.65 | $265,000.00 |
DisclosureSEC source: 0001477932-25-008466 · form4.xml · nonDerivative · entry 1 Salkind Gene · CIK 0001592481 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 569,470 Read SEC document |
| October 01, 2025 Filed Nov 21, 2025 11:32 UTC |
Norstrud Andrew JamesDirector · Chief Financial Officer
|
GrantCommon Stock | 240,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-25-008534 · form4.xml · nonDerivative · entry 1 Norstrud Andrew James · CIK 0001311402 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: Not disclosed F1 · shares: Vests quarterly in equal installments over 12 months beginning October 1, 2026. F2 · shares: The shares of Common Stock reported herein were granted pursuant to the Issuer's Equity Incentive Plan. Read SEC document |
| October 01, 2025 Filed Dec 17, 2025 23:43 UTC |
MARSHALL ALLANDirector · Chief Executive Officer
|
GrantCommon Stock | 1,600,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-25-009027 · form4.xml · nonDerivative · entry 1 MARSHALL ALLAN · CIK 0001279925 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,846,261 F1 · shares: Vests quarterly in equal installments over 12 months beginning October 1, 2025. F2 · shares: The shares of Common Stock reported herein were granted pursuant to the Issuer's Equity Incentive Plan. Read SEC document |
| July 22, 2025 Filed Jul 24, 2025 20:05 UTC |
Dugan LawrenceDirector
|
PurchaseCommon Stock | 4,000 | $7.50 | $30,000.00 |
DisclosureSEC source: 0001477932-25-005238 · form4.xml · nonDerivative · entry 6 Dugan Lawrence · CIK 0001864559 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,389 Read SEC document |
| July 16, 2025 Filed Jul 24, 2025 20:09 UTC | GrantCommon Stock | 400,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-25-005239 · form4.xml · nonDerivative · entry 1 Rudick Brian Benjamin · CIK 0002068669 · CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 838,597 F1 · shares: Vests monthly in equal installments over 12 months beginning July 1, 2025. F2 · shares: The shares of Common Stock reported herein were granted pursuant to the Issuer's Equity Incentive Plan. Read SEC document |
|
| July 16, 2025 Filed Jul 24, 2025 20:05 UTC |
Dugan LawrenceDirector
|
PurchaseCommon Stock | 1,000 | $5.60 | $5,600.00 |
DisclosureSEC source: 0001477932-25-005238 · form4.xml · nonDerivative · entry 5 Dugan Lawrence · CIK 0001864559 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,389 Read SEC document |
| July 16, 2025 Filed Jul 24, 2025 20:05 UTC |
Dugan LawrenceDirector
|
PurchaseCommon Stock | 10,000 | $5.70 | $57,000.00 |
DisclosureSEC source: 0001477932-25-005238 · form4.xml · nonDerivative · entry 4 Dugan Lawrence · CIK 0001864559 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,389 Read SEC document |
| July 16, 2025 Filed Jul 24, 2025 20:05 UTC |
Dugan LawrenceDirector
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-25-005238 · form4.xml · nonDerivative · entry 3 Dugan Lawrence · CIK 0001864559 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,389 F2 · shares: Vests quarterly in equal installments over 12 months beginning July 1, 2025. F3 · shares: The shares of Common Stock reported herein were granted pursuant to the Issuer's Equity Incentive Plan. Read SEC document |
| July 16, 2025 Filed Jul 24, 2025 20:05 UTC |
Dugan LawrenceDirector
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-25-005238 · form4.xml · nonDerivative · entry 2 Dugan Lawrence · CIK 0001864559 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,389 F1 · shares: Vests in full 90 days from July 1, 2025. F3 · shares: The shares of Common Stock reported herein were granted pursuant to the Issuer's Equity Incentive Plan. Read SEC document |
| July 16, 2025 Filed Jul 24, 2025 16:03 UTC |
Williams Thomas CharlesDirector
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-25-005237 · form4.xml · nonDerivative · entry 2 Williams Thomas Charles · CIK 0001474253 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 F2 · shares: Vests quarterly in equal installments over 12 months beginning July 1, 2025. F3 · shares: The shares of Common Stock reported herein were granted pursuant to the Issuer's Equity Incentive Plan. Read SEC document |
| July 16, 2025 Filed Jul 24, 2025 16:03 UTC |
Williams Thomas CharlesDirector
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-25-005237 · form4.xml · nonDerivative · entry 1 Williams Thomas Charles · CIK 0001474253 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 F1 · shares: Vests in full 90 days from July 1, 2025. F3 · shares: The shares of Common Stock reported herein were granted pursuant to the Issuer's Equity Incentive Plan. Read SEC document |
| July 16, 2025 Filed Jul 24, 2025 20:03 UTC |
MARSHALL ALLANDirector · Chief Executive Officer · 10% owner
|
GrantCommon Stock | 1,200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-25-005236 · form4.xml · nonDerivative · entry 2 MARSHALL ALLAN · CIK 0001279925 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,246,261 F2 · shares: Vests in full 30 days from July 1, 2025. F3 · shares: The shares of Common Stock reported herein were granted pursuant to the Issuer's Equity Incentive Plan. Read SEC document |
| July 16, 2025 Filed Jul 24, 2025 20:02 UTC |
Norstrud Andrew JamesDirector · Chief Financial Officer
|
GrantCommon Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-25-005235 · form4.xml · nonDerivative · entry 1 Norstrud Andrew James · CIK 0001311402 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 409,138 F1 · shares: Vests monthly in equal installments over 12 months beginning July 1, 2025. F2 · shares: The shares of Common Stock reported herein were granted pursuant to the Issuer's Equity Incentive Plan. Read SEC document |
| July 16, 2025 Filed Jul 30, 2025 20:47 UTC |
Salkind GeneDirector · 10% owner
|
GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-25-005338 · form4.xml · nonDerivative · entry 3 Salkind Gene · CIK 0001592481 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 585,370 F3 · shares: Vests quarterly in equal installments over 12 months beginning July 1, 2025. F4 · shares: The shares of Common Stock reported herein were granted pursuant to the Issuer's Equity Incentive Plan. Read SEC document |
| July 16, 2025 Filed Jul 30, 2025 20:47 UTC |
Salkind GeneDirector · 10% owner
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-25-005338 · form4.xml · nonDerivative · entry 2 Salkind Gene · CIK 0001592481 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 435,370 F2 · shares: Vests in full 90 days from July 1, 2025. F4 · shares: The shares of Common Stock reported herein were granted pursuant to the Issuer's Equity Incentive Plan. Read SEC document |
| July 15, 2025 Filed Jul 24, 2025 20:05 UTC |
Dugan LawrenceDirector
|
PurchaseCommon Stock | 1,000 | $5.17 | $5,170.00 |
DisclosureSEC source: 0001477932-25-005238 · form4.xml · nonDerivative · entry 1 Dugan Lawrence · CIK 0001864559 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,389 Read SEC document |
| July 11, 2025 Filed Jul 24, 2025 20:03 UTC |
MARSHALL ALLANDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Stock | 161,943 | $4.94 | $799,998.42 |
DisclosureSEC source: 0001477932-25-005236 · form4.xml · nonDerivative · entry 1 MARSHALL ALLAN · CIK 0001279925 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,046,261 F1 · shares: The Reporting Person purchased these shares pursuant to a private placement offering conducted by the Issuer. The Common Stock is being offered pursuant to the exemption from registration under Section 4(a)(2) of the Securities Act of 1933, as amended and Rule 506(b) of Regulation D promulgated thereunder, and applicable state securities laws. Read SEC document |
| July 11, 2025 Filed Jul 30, 2025 20:47 UTC |
Salkind GeneDirector · 10% owner
|
PurchaseCommon Stock | 20,243 | $4.94 | $100,000.42 |
DisclosureSEC source: 0001477932-25-005338 · form4.xml · nonDerivative · entry 1 Salkind Gene · CIK 0001592481 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 385,370 F1 · shares: The Reporting Person purchased these shares pursuant to a private placement offering conducted by the Issuer. The Common Stock is being offered pursuant to the exemption from registration under Section 4(a)(2) of the Securities Act of 1933, as amended and Rule 506(b) of Regulation D promulgated thereunder, and applicable state securities laws. Read SEC document |
| April 17, 2025 Filed Apr 25, 2025 20:01 UTC |
MARSHALL ALLANDirector · Chief Executive Officer · 10% owner
|
GrantWarrants to purchase Common Stock · Derivative | 500,000 | $0.00 Strike: $2.28 | $0.00 |
DisclosureSEC source: 0001477932-25-002981 · form4.xml · derivative · entry 4 MARSHALL ALLAN · CIK 0001279925 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2030-04-17 F5 · kind: The warrants were awarded to the Reporting Person as compensation pursuant to his employment agreement. The warrants and the underlying shares are restricted securities subject to Rule 144 of the Securities Act. The warrants are exercisable immediately until their expiration date. F5 · derivative.exercise_date: The warrants were awarded to the Reporting Person as compensation pursuant to his employment agreement. The warrants and the underlying shares are restricted securities subject to Rule 144 of the Securities Act. The warrants are exercisable immediately until their expiration date. Read SEC document |
| April 17, 2025 Filed Apr 25, 2025 20:01 UTC |
MARSHALL ALLANDirector · Chief Executive Officer · 10% owner
|
GrantCommon Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-25-002981 · form4.xml · nonDerivative · entry 2 MARSHALL ALLAN · CIK 0001279925 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 884,318 F2 · kind: This award of the Shares is being made pursuant to the Issuer's Restricted Stock Award Agreement, subject to the following vesting schedule: 100% of the Shares vest on October 14, 2025. A portion of all of this award may be forfeited in the event of termination of employment. Read SEC document |
| April 17, 2025 Filed Apr 25, 2025 20:01 UTC |
MARSHALL ALLANDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Stock | 657,895 | $2.28 | $1,500,000.60 |
DisclosureSEC source: 0001477932-25-002981 · form4.xml · nonDerivative · entry 1 MARSHALL ALLAN · CIK 0001279925 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 809,318 F1 · shares: The Reporting Person purchased these shares in a PIPE offering conducted by the Issuer. The shares are restricted securities subject to transfer restrictions under Rule 144 of the Securities Act until such time that they are registered pursuant to a registration statement or become eligible for resale otherwise. Read SEC document |
| April 17, 2025 Filed Apr 25, 2025 20:01 UTC |
Norstrud Andrew JamesDirector · Chief Financial Officer
|
GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-25-002980 · form4.xml · nonDerivative · entry 2 Norstrud Andrew James · CIK 0001311402 · Director · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 159,138 F2 · kind: This award of the Shares is being made pursuant to the Issuer's Restricted Stock Award Agreement, subject to the following vesting schedule: 10,000 Shares vest per month over a period of 10 months commencing April 17, 2025. A portion of all of this award may be forfeited in the event of termination of employment. Read SEC document |
| April 17, 2025 Filed Apr 25, 2025 20:01 UTC |
Norstrud Andrew JamesDirector · Chief Financial Officer
|
PurchaseCommon Stock | 43,860 | $2.28 | $100,000.80 |
DisclosureSEC source: 0001477932-25-002980 · form4.xml · nonDerivative · entry 1 Norstrud Andrew James · CIK 0001311402 · Director · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 59,138 F1 · shares: The Reporting Person purchased these shares in a PIPE offering conducted by the Issuer. The shares are restricted securities subject to transfer restrictions under Rule 144 of the Securities Act until such time that they are registered pursuant to a registration statement or become eligible for resale otherwise. Read SEC document |
| April 17, 2025 Filed Apr 25, 2025 20:01 UTC |
Salkind GeneDirector · 10% owner
|
GrantOptions to buy common stock · Derivative | 35,000 | $0.00 Strike: $2.28 | $0.00 |
DisclosureSEC source: 0001477932-25-002979 · form4.xml · derivative · entry 3 Salkind Gene · CIK 0001592481 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common · 35,000 shares Expires 2035-04-17 F2 · derivative.exercise_date: 100% of the options vest on April 17, 2026. Read SEC document |
| April 17, 2025 Filed Apr 25, 2025 20:01 UTC |
Salkind GeneDirector · 10% owner
|
PurchaseCommon Stock | 241,229 | $2.28 | $550,002.12 |
DisclosureSEC source: 0001477932-25-002979 · form4.xml · nonDerivative · entry 1 Salkind Gene · CIK 0001592481 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 365,127 F1 · shares: The Reporting Person purchased these shares in a PIPE offering conducted by the Issuer. The shares are restricted securities subject to transfer restrictions under Rule 144 of the Securities Act until such time that they are registered pursuant to a registration statement or become eligible for resale otherwise. Read SEC document |
| March 12, 2025 Filed Apr 25, 2025 20:01 UTC |
MARSHALL ALLANDirector · Chief Executive Officer · 10% owner
|
PurchaseConvertible Preferred Stock · Derivative | 125,000 | $2.60 Strike: $2.60 | $325,000.00 |
DisclosureSEC source: 0001477932-25-002981 · form4.xml · derivative · entry 3 MARSHALL ALLAN · CIK 0001279925 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires not disclosed F3 · derivative.exercise_date: These Shares are convertible to Common Stock immediately. F4 · derivative.expiration_date: The Preferred Stock is perpetual and therefore has no expiration date. Read SEC document |
| January 17, 2025 Filed Apr 25, 2025 20:01 UTC |
Dugan LawrenceDirector
|
GrantOptions to buy common stock · Derivative | 25,000 | $0.00 Strike: $3.46 | $0.00 |
DisclosureSEC source: 0001477932-25-002978 · form4.xml · derivative · entry 1 Dugan Lawrence · CIK 0001864559 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common · 25,000 shares Expires 2035-01-17 Read SEC document |
| January 17, 2025 Filed Apr 25, 2025 16:01 UTC |
Williams Thomas CharlesDirector
|
GrantOptions to buy common stock · Derivative | 25,000 | $0.00 Strike: $3.46 | $0.00 |
DisclosureSEC source: 0001477932-25-002982 · form4.xml · derivative · entry 1 Williams Thomas Charles · CIK 0001474253 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2035-01-17 Read SEC document |
| January 17, 2025 Filed Apr 25, 2025 20:01 UTC |
Salkind GeneDirector · 10% owner
|
GrantOptions to buy common stock · Derivative | 25,000 | $0.00 Strike: $3.46 | $0.00 |
DisclosureSEC source: 0001477932-25-002979 · form4.xml · derivative · entry 2 Salkind Gene · CIK 0001592481 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common · 25,000 shares Expires 2035-01-17 Read SEC document |
| March 12, 2024 Filed Mar 18, 2024 20:55 UTC |
MARSHALL ALLANDirector · CHIEF EXECUTIVE OFFICER · 10% owner
|
PurchaseCommon Stock | 64,150 | $0.57 | $36,565.50 |
DisclosureSEC source: 0001415889-24-008293 · form4-03182024_080308.xml · nonDerivative · entry 2 MARSHALL ALLAN · CIK 0001279925 · Director · CHIEF EXECUTIVE OFFICER · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,939,654 Read SEC document |
| March 11, 2024 Filed Mar 18, 2024 20:55 UTC |
MARSHALL ALLANDirector · CHIEF EXECUTIVE OFFICER · 10% owner
|
PurchaseCommon Stock | 13,623 | $0.60 | $8,173.80 |
DisclosureSEC source: 0001415889-24-008293 · form4-03182024_080308.xml · nonDerivative · entry 1 MARSHALL ALLAN · CIK 0001279925 · Director · CHIEF EXECUTIVE OFFICER · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,875,504 Read SEC document |
| March 05, 2024 Filed Mar 6, 2024 20:04 UTC |
MARSHALL ALLANDirector · CHIEF EXECUTIVE OFFICER · 10% owner
|
PurchaseCommon Stock | 103,013 | $0.70 | $72,109.10 |
DisclosureSEC source: 0001415889-24-006986 · form4-03062024_080338.xml · nonDerivative · entry 1 MARSHALL ALLAN · CIK 0001279925 · Director · CHIEF EXECUTIVE OFFICER · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,861,881 Read SEC document |
| December 15, 2023 Filed Dec 20, 2023 18:37 UTC |
MARSHALL ALLANDirector · CHIEF EXECUTIVE OFFICER · 10% owner
|
PurchaseCommon Stock | 4,535 | $0.91 | $4,126.85 |
DisclosureSEC source: 0001415889-23-016775 · form4-12202023_061212.xml · nonDerivative · entry 1 MARSHALL ALLAN · CIK 0001279925 · Director · CHIEF EXECUTIVE OFFICER · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,758,868 Read SEC document |
| December 14, 2023 Filed Dec 20, 2023 18:37 UTC |
MARSHALL ALLANDirector · CHIEF EXECUTIVE OFFICER · 10% owner
|
PurchaseCommon Stock | 8,381 | $0.98 | $8,213.38 |
DisclosureSEC source: 0001415889-23-016775 · form4-12202023_061212.xml · nonDerivative · entry 2 MARSHALL ALLAN · CIK 0001279925 · Director · CHIEF EXECUTIVE OFFICER · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,767,249 Read SEC document |
| December 07, 2023 Filed Dec 7, 2023 19:42 UTC |
MARSHALL ALLANDirector · CHIEF EXECUTIVE OFFICER · 10% owner
|
PurchaseCommon Stock | 90,001 | $0.94 | $84,951.94 |
DisclosureSEC source: 0001415889-23-015961 · form4-12072023_071233.xml · nonDerivative · entry 1 MARSHALL ALLAN · CIK 0001279925 · Director · CHIEF EXECUTIVE OFFICER · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,754,333 Read SEC document |
| December 05, 2023 Filed Dec 6, 2023 19:47 UTC |
MARSHALL ALLANDirector · CHIEF EXECUTIVE OFFICER · 10% owner
|
PurchaseCommon Stock | 19,296 | $0.84 | $16,293.54 |
DisclosureSEC source: 0001415889-23-015923 · form4-12062023_071208.xml · nonDerivative · entry 2 MARSHALL ALLAN · CIK 0001279925 · Director · CHIEF EXECUTIVE OFFICER · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,664,332 Read SEC document |
| December 04, 2023 Filed Dec 6, 2023 19:47 UTC |
MARSHALL ALLANDirector · CHIEF EXECUTIVE OFFICER · 10% owner
|
PurchaseCommon Stock | 34,178 | $0.71 | $24,358.66 |
DisclosureSEC source: 0001415889-23-015923 · form4-12062023_071208.xml · nonDerivative · entry 1 MARSHALL ALLAN · CIK 0001279925 · Director · CHIEF EXECUTIVE OFFICER · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,645,036 Read SEC document |
| November 15, 2023 Filed Nov 30, 2023 00:02 UTC |
MARSHALL ALLANDirector · CHIEF EXECUTIVE OFFICER · 10% owner
|
PurchaseCommon Stock Warrants · Derivative | 375,000 | $0.00 Strike: $1.10 | $0.00 |
DisclosureSEC source: 0001415889-23-015600 · form4-11302023_121125.xml · derivative · entry 1 MARSHALL ALLAN · CIK 0001279925 · Director · CHIEF EXECUTIVE OFFICER · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,458,333 Underlying: Common Stock · 375,000 shares Expires 2028-11-15 Read SEC document |
| June 28, 2023 Filed Jul 7, 2023 19:02 UTC |
MARSHALL ALLANDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Stock | 24,000 | $2.26 | $54,168.00 |
DisclosureSEC source: 0001477932-23-005103 · form4.xml · nonDerivative · entry 5 MARSHALL ALLAN · CIK 0001279925 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,690,803 F1 · price: This transaction was executed in multiple trades at prices ranging from $2.25 to $2.45. The price reported above reflects the average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 27, 2023 Filed Jul 7, 2023 19:02 UTC |
MARSHALL ALLANDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Stock | 24,000 | $2.39 | $57,288.00 |
DisclosureSEC source: 0001477932-23-005103 · form4.xml · nonDerivative · entry 4 MARSHALL ALLAN · CIK 0001279925 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,666,803 F1 · price: This transaction was executed in multiple trades at prices ranging from $2.25 to $2.45. The price reported above reflects the average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.